Phase IIa Trial of Anti-CD19 CAR T-Cells in Systemic Sclerosis Resistant to Immunosuppressive Therapy

NCT07493395 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
6
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital, Montpellier